Avedro, Inc. to Report First Quarter 2019 Financial Results on May 9, 2019
April 25, 2019 16:05 ET
|
Avedro, Inc
WALTHAM, Mass., April 25, 2019 (GLOBE NEWSWIRE) -- Avedro, Inc. (Nasdaq: AVDR) (“Avedro”) today announced that it will release financial results for the first quarter of 2019 after the close of...
Avedro to Present Research on Proprietary Corneal Cross-Linking Technologies at 2019 ARVO Annual Meeting
April 22, 2019 16:05 ET
|
Avedro, Inc
WALTHAM, Mass., April 22, 2019 (GLOBE NEWSWIRE) -- Avedro, Inc. (Nasdaq: AVDR) (Avedro), today announced that three abstracts highlighting proprietary cross-linking technologies being developed by...
UPDATE -- Avedro Reaches Reimbursement Milestone for Its FDA-Approved Procedure for Progressive Keratoconus
April 05, 2019 09:00 ET
|
Avedro, Inc
WALTHAM, Mass., April 05, 2019 (GLOBE NEWSWIRE) -- Avedro, Inc., (Avedro or the company), today announced that four new providers --Providence Health Plan in the Pacific Northwest, Health New...
Avedro Reaches Reimbursement Milestone for Its FDA-Approved Procedure for Progressive Keratoconus
April 05, 2019 07:00 ET
|
Avedro, Inc
WALTHAM, Mass., April 05, 2019 (GLOBE NEWSWIRE) -- Avedro, Inc., (Avedro or the company), today announced that four new providers --Providence Health Plan in the Pacific Northwest, Health New...
Avedro, Inc. Announces Fourth Quarter and Full Year 2018 Financial Results and Provides Full Year 2019 Financial Outlook
March 21, 2019 16:05 ET
|
Avedro, Inc
WALTHAM, Mass., March 21, 2019 (GLOBE NEWSWIRE) -- Avedro, Inc. (Nasdaq: AVDR) (“Avedro”), a leading commercial-stage ophthalmic medical technology company focused on treating corneal ectatic...
Avedro, Inc. Announces Appointment of Patrick B. Jacques as Vice President of Sales
March 13, 2019 16:05 ET
|
Avedro, Inc
WALTHAM, Mass., March 13, 2019 (GLOBE NEWSWIRE) -- Avedro, Inc. (Nasdaq: AVDR) (“Avedro”), a leading commercial-stage ophthalmic medical technology company focused on treating corneal ectatic...
Avedro, Inc. to Report Fourth Quarter and Full Year 2018 Financial Results on March 21, 2019
February 28, 2019 16:05 ET
|
Avedro, Inc
WALTHAM, Mass., Feb. 28, 2019 (GLOBE NEWSWIRE) -- Avedro, Inc. (Nasdaq: AVDR) (“Avedro”), a leading commercial-stage ophthalmic medical technology company focused on treating corneal ectatic...
Avedro Announces Pricing of Initial Public Offering
February 13, 2019 21:19 ET
|
Avedro, Inc
WALTHAM, Mass., Feb. 13, 2019 (GLOBE NEWSWIRE) -- Avedro, Inc. (Nasdaq: AVDR) (“Avedro”), a leading commercial-stage ophthalmic medical technology company focused on treating corneal ectatic...
Avedro Launches Initial Public Offering
February 04, 2019 08:13 ET
|
Avedro, Inc
WALTHAM, Mass., Feb. 04, 2019 (GLOBE NEWSWIRE) -- Avedro, Inc. (“Avedro”), a leading commercial-stage ophthalmic medical technology company focused on treating corneal ectatic disorders and...